Autopsy report · NCT05582681

HCV Test and Treat Utilizing Simplified HCV Patient Education

“The funding was halted.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Hepatitis C

Interventions

Cepheid POC HCV Viremia (RNA) test; HCV education from a health care provider; Glecaprevir and Pibrentasvir

Participants

8

Sites

3

Countries

United States

Trials that died the same way

• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (90% match in meaning)
• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (85% match in meaning)
• Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes
  “Funding issues meant that development of the study was halted.” (80% match in meaning)
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
  “Funding ceased” (80% match in meaning)
• Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects
  “Funding ended.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.